Formulation and Engineering of Biomaterials
Amyloid fibrils as functionalizable components of nanocomposite materials
Article first published online: 14 OCT 2011
DOI: 10.1002/btpr.726
Copyright © 2011 American Institute of Chemical Engineers (AIChE)
Additional Information
How to Cite
Rao, S. P., Meade, S. J., Healy, J. P., Sutton, K. H., Larsen, N. G., Staiger, M. P. and Gerrard, J. A. (2012), Amyloid fibrils as functionalizable components of nanocomposite materials. Biotechnol Progress, 28: 248–256. doi: 10.1002/btpr.726
Publication History
- Issue published online: 2 FEB 2012
- Article first published online: 14 OCT 2011
- Accepted manuscript online: 12 SEP 2011 02:10PM EST
- Manuscript Revised: 15 AUG 2011
- Manuscript Received: 28 JUN 2011
- Abstract
- Article
- References
- Cited By
Keywords:
- amyloid protein fibril;
- bionanocomposite;
- thermomechanical properties;
- microstructure;
- poly(vinyl alcohol)
Abstract
Amyloid fibrils are a form of protein nanofiber that show promise as components of multifunctional bionanomaterials. In this work, native bovine insulin and bovine insulin that had been previously converted into amyloid fibrils were combined with poly(vinyl alcohol) (PVOH) via solution casting to determine the effect of fibrillization on the thermomechanical properties of the resulting composite. The synthesis method was found to preserve the amyloid fibril structure and properties of the resulting fibril-PVOH composite were investigated. At a filling level of 0.6 wt %, the fibril-reinforced PVOH was 15% stiffer than the PVOH control. Various properties of the films, including the glass transition temperature, degradation temperature, microstructure, and film morphology were characterized. Although more work is required to optimize the properties of the composites, this study provides proof of principle that incorporation of amyloid fibrils into a polymeric material can impart useful changes to the mechanical and morphological properties of the films. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012

1520-6033/asset/BTPR_left.gif?v=1&s=a5be2ff5a0fe6ccdaad74a6d128c142e5f71a8da)
1520-6033/asset/BTPR_right.gif?v=1&s=992d113a3e61fc9d3571812359165df86cf830e4)
